Institutional Ownership Autolus Therapeutics PLC (AUTL)
This table provides information about the institutional ownership of Autolus Therapeutics PLC (AUTL). We have compiled data on the 99 institutions that hold shares in the stock, with a total of 163 Million shares, which have been reported (via 13F filing form) to have a value of $394 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
27,091,700
shares
|
$65.6 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Blackstone Inc
New York, NY |
May 15, 2025 Q1 2025 |
20,485,611
shares
|
$49.6 Million
0.14% of portfolio
|
Q4 2022
Added 13.9%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
17,849,482
shares
|
$43.2 Million
0.97% of portfolio
|
Q1 2025
Added 25.53%
|
|
|
Syncona Portfolio LTD
Guernsey, Channel Islands, X0 |
May 07, 2025 Q1 2025 |
16,640,720
shares
|
$40.3 Million
97.79% of portfolio
|
Q4 2024
Reduced 10.31%
|
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
11,000,000
shares
|
$26.6 Million
0.26% of portfolio
|
Q1 2025
Added 19.57%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
9,910,642
shares
|
$24 Million
0.25% of portfolio
|
Q4 2024
Reduced 19.72%
|
|
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
May 15, 2025 Q1 2025 |
8,600,000
shares
|
$20.8 Million
3.85% of portfolio
|
Q1 2025
Added 4.24%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
4,623,324
shares
|
$11.2 Million
0.45% of portfolio
|
Q1 2024
Added 23.39%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,436,102
shares
|
$10.7 Million
0.0% of portfolio
|
Q2 2024
Added 9.37%
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
3,608,490
shares
|
$8.73 Million
0.01% of portfolio
|
Q1 2025
Added 25.97%
|
|
|
Laurion Capital Management LP
New York, NY |
May 15, 2025 Q1 2025 |
3,369,248
shares
|
$8.15 Million
0.14% of portfolio
|
Q1 2025
Added 5.63%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
3,191,401
shares
|
$7.72 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
3,126,167
shares
|
$7.57 Million
0.02% of portfolio
|
Q1 2025
Added 71.33%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
3,045,000
shares
|
$7.37 Million
0.53% of portfolio
|
Q1 2025
Reduced 32.33%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
2,900,186
shares
|
$7.02 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.33%
|
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
2,728,910
shares
|
$6.6 Million
2.61% of portfolio
|
Q1 2025
Reduced 9.32%
|
|
|
Odey Asset Management Group LTD
London, X0 |
May 15, 2023 Q1 2023 |
2,499,400
shares
|
$6.05 Million
1.52% of portfolio
|
Q4 2022
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
1,986,190
shares
|
$4.81 Million
0.0% of portfolio
|
Q1 2025
Added 20.14%
|
|
|
Pendal Group LTD
|
Jan 19, 2023 Q4 2022 |
1,733,391
shares
|
$4.19 Million
0.03% of portfolio
|
Q4 2022
Added 26.46%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,584,125
shares
|
$3.83 Million
0.0% of portfolio
|
Q1 2025
Added 155.94%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,410,104
shares
|
$3.41 Million
0.0% of portfolio
|
Q1 2025
Added 31.6%
|
|
|
Health Invest Partners Ab
|
Jul 14, 2025 Q2 2025 |
1,105,461
shares
|
$2.68 Million
1.14% of portfolio
|
Q2 2025
Added 130.48%
|
|
|
Perpetual LTD
Sydney, New South Wales, C3 |
Jul 11, 2025 Q2 2025 |
829,090
shares
|
$2.01 Million
0.02% of portfolio
|
Q2 2025
Reduced 32.25%
|
|
|
Alphabet Inc.
Mountain View, CA |
May 01, 2025 Q1 2025 |
698,262
shares
|
$1.69 Million
0.1% of portfolio
|
Q2 2020
Reduced 0.16%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
619,913
shares
|
$1.5 Million
0.0% of portfolio
|
Q1 2025
Reduced 18.17%
|